NCT05912764Recruiting
Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma
Evaluation of Early Home Return Care Pathway in Patients Who Have Undergone Endoscopic Enucleation of Prostate Adenoma by Laser
Source: ClinicalTrials.gov · Last updated 24 Nov 2025
Brief summary (registry, in English)
Prostate adenoma management includes, if necessary, surgical treatments: resection or vaporization by endoscopy or by open surgery in case of a very large prostate. Laser technology is a curative treatment for prostate adenoma. The minimum duration of hospitalization, in the context of enucleation prostatic endoscopy by laser, is estimated at 48 hours. The Union Clinique has developed an improved rehabilitation care pathway reducing hospitalization duration to 24 hours (one night hospitalization). This care pathway involves patient as an actor in its care but also health professionals, in particular nurses. This study is based on the hypothesis that the model developed by the Union Clinique can be translated to other healthcare establishments and that home return supervized by nurses allows reducing hospital stay length without increasing the risk of serious complications for patients
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 440 (estimated)
- First submitted
- 12 Jun 2023
- Start date
- 26 Jan 2024
- Primary completion date
- 15 Aug 2027
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- NCT number
- NCT05912764
What you commit to
- Study type: Interventional
- Planned participants: 440
- From 26 Jan 2024 to the primary completion date, 15 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Bedridden patient or WHO clinical condition \>2
Lab values
- Patient with double anti-platelet aggregation who cannot be interrupted
Other
- Patient living beyond the scope of care by the nurses coordination
- Patient requiring curative anticoagulation which cannot be interrupted or relayed at home by heparin
Who the study is looking for
- Patient planned for endoscopic enucleation of prostate adenoma with laser
- Patient with symptomatic benign prostatic hyperplasia and refractory to medical reatment and/or
- Patient with benign prostatic hyperplasia complicated by chronic retention of urine and/or
- Patient with benign prostatic hyperplasia complicated by prostatitis and/or
- Patient with symptomatic benign prostatic hyperplasia
Age in the registry: 45 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinique de l'Union Coordinator of this site? Confirm its status | Saint-Jean | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.